Literature DB >> 30108916

Applications and perspectives of nanomaterials in novel vaccine development.

Yingbin Shen1, Tianyao Hao1, Shiyi Ou1, Churan Hu1, Long Chen1.   

Abstract

Vaccines show great potential for both prophylactic and therapeutic use in infections, cancer, and other diseases. With the rapid development of bio-technologies and materials sciences, nanomaterials are playing essential roles in novel vaccine formulations and can boost antigen effectiveness by operating as delivery systems to enhance antigen processing and/or as immune-potentiating adjuvants to induce or potentiate immune responses. The effect of nanoparticles in vaccinology showed enhanced antigen stability and immunogenicity as well as targeted delivery and slow release. However, obstacles remain due to the lack of fundamental knowledge on the detailed molecular working mechanism and in vivo bio-effects of nanoparticles. This review provides a broad overview of the current improvements in nanoparticles in vaccinology. Modern nanoparticle vaccines are classified by the nanoparticles' action based on either delivery system or immune potentiator approaches. The mechanisms of interaction of nanoparticles with the antigens and the immune system are discussed. Nanoparticle vaccines approved for use are also listed. A fundamental understanding of the in vivo bio-distribution and the fate of nanoparticles will accelerate the rational design of new nanoparticles comprising vaccines in the future.

Entities:  

Year:  2017        PMID: 30108916      PMCID: PMC6083789          DOI: 10.1039/c7md00158d

Source DB:  PubMed          Journal:  Medchemcomm        ISSN: 2040-2503            Impact factor:   3.597


  122 in total

1.  Protection of erythrocytes from human complement-mediated lysis by membrane-targeted recombinant soluble CD59: a new approach to PNH therapy.

Authors:  Anita Hill; Simon H Ridley; Dirk Esser; Rodney G Oldroyd; Matthew J Cullen; Paula Kareclas; Seán Gallagher; Geoffrey P Smith; Stephen J Richards; Jennifer White; Richard A G Smith; Peter Hillmen
Journal:  Blood       Date:  2005-12-01       Impact factor: 22.113

2.  Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type.

Authors:  Kostas Kostarelos; Lara Lacerda; Giorgia Pastorin; Wei Wu; Sébastien Wieckowski; Jacqueline Luangsivilay; Sylvie Godefroy; Davide Pantarotto; Jean-Paul Briand; Sylviane Muller; Maurizio Prato; Alberto Bianco
Journal:  Nat Nanotechnol       Date:  2007-01-28       Impact factor: 39.213

3.  Single-Vehicular Delivery of Antagomir and Small Molecules to Inhibit miR-122 Function in Hepatocellular Carcinoma Cells by using "Smart" Mesoporous Silica Nanoparticles.

Authors:  Changmin Yu; Linghui Qian; Mahesh Uttamchandani; Lin Li; Shao Q Yao
Journal:  Angew Chem Int Ed Engl       Date:  2015-07-15       Impact factor: 15.336

Review 4.  Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.

Authors:  John C Kraft; Jennifer P Freeling; Ziyao Wang; Rodney J Y Ho
Journal:  J Pharm Sci       Date:  2013-11-25       Impact factor: 3.534

5.  Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells.

Authors:  Hélène Dumortier; Stéphanie Lacotte; Giorgia Pastorin; Riccardo Marega; Wei Wu; Davide Bonifazi; Jean-Paul Briand; Maurizio Prato; Sylviane Muller; Alberto Bianco
Journal:  Nano Lett       Date:  2006-07       Impact factor: 11.189

6.  Targeting transmembrane TNF-α suppresses breast cancer growth.

Authors:  Mingxia Yu; Xiaoxi Zhou; Lin Niu; Guohong Lin; Jin Huang; Wenjing Zhou; Hui Gan; Jing Wang; Xiaodan Jiang; Bingjiao Yin; Zhuoya Li
Journal:  Cancer Res       Date:  2013-06-21       Impact factor: 12.701

7.  Assessment of efficacy and safety of various adjuvant formulations with a total soluble extract of Trichinella spiralis.

Authors:  J Aucouturier; S Deville; C Perret; I Vallée; P Boireau
Journal:  Parasite       Date:  2001-06       Impact factor: 3.000

8.  TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis.

Authors:  Stacey L Demento; Nathalie Bonafé; Weiguo Cui; Susan M Kaech; Michael J Caplan; Erol Fikrig; Michel Ledizet; Tarek M Fahmy
Journal:  J Immunol       Date:  2010-07-26       Impact factor: 5.422

9.  Monetite and brushite coated magnesium: in vivo and in vitro models for degradation analysis.

Authors:  Shaylin Shadanbaz; Jemimah Walker; Tim B F Woodfield; Mark P Staiger; George J Dias
Journal:  J Mater Sci Mater Med       Date:  2013-10-01       Impact factor: 3.896

Review 10.  Functional nanomaterials can optimize the efficacy of vaccines.

Authors:  Ye Liu; Yingying Xu; Yue Tian; Chunying Chen; Chen Wang; Xingyu Jiang
Journal:  Small       Date:  2014-09-19       Impact factor: 13.281

View more
  12 in total

Review 1.  Carbon nanostructures: a comprehensive review of potential applications and toxic effects.

Authors:  Maryam Farmand; Fatemeh Jahanpeyma; Alieh Gholaminejad; Mostafa Azimzadeh; Fatemeh Malaei; Nahid Shoaie
Journal:  3 Biotech       Date:  2022-07-06       Impact factor: 2.893

Review 2.  Immunomodulatory Nanosystems.

Authors:  Xiangru Feng; Weiguo Xu; Zhongmin Li; Wantong Song; Jianxun Ding; Xuesi Chen
Journal:  Adv Sci (Weinh)       Date:  2019-06-21       Impact factor: 16.806

Review 3.  Integrating Biomaterials and Immunology to Improve Vaccines Against Infectious Diseases.

Authors:  Lampouguin Yenkoidiok-Douti; Christopher M Jewell
Journal:  ACS Biomater Sci Eng       Date:  2020-01-12

Review 4.  Bacterial microcompartments: catalysis-enhancing metabolic modules for next generation metabolic and biomedical engineering.

Authors:  Henning Kirst; Cheryl A Kerfeld
Journal:  BMC Biol       Date:  2019-10-10       Impact factor: 7.431

Review 5.  A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues.

Authors:  Shahad Saif Khandker; Brian Godman; Md Irfan Jawad; Bushra Ayat Meghla; Taslima Akter Tisha; Mohib Ullah Khondoker; Md Ahsanul Haq; Jaykaran Charan; Ali Azam Talukder; Nafisa Azmuda; Shahana Sharmin; Mohd Raeed Jamiruddin; Mainul Haque; Nihad Adnan
Journal:  Vaccines (Basel)       Date:  2021-11-24

Review 6.  Recent Advances and Future Perspectives in Polymer-Based Nanovaccines.

Authors:  Natassa Pippa; Maria Gazouli; Stergios Pispas
Journal:  Vaccines (Basel)       Date:  2021-05-26

Review 7.  Revolutionizing polymer-based nanoparticle-linked vaccines for targeting respiratory viruses: A perspective.

Authors:  Yinghan Chan; Sin Wi Ng; Sachin Kumar Singh; Monica Gulati; Gaurav Gupta; Sushil Kumar Chaudhary; Goh Bey Hing; Trudi Collet; Ronan MacLoughlin; Raimar Löbenberg; Brian G Oliver; Dinesh Kumar Chellappan; Kamal Dua
Journal:  Life Sci       Date:  2021-06-24       Impact factor: 6.780

Review 8.  Immune-mediated approaches against COVID-19.

Authors:  Helena F Florindo; Ron Kleiner; Daniella Vaskovich-Koubi; Rita C Acúrcio; Barbara Carreira; Eilam Yeini; Galia Tiram; Yulia Liubomirski; Ronit Satchi-Fainaro
Journal:  Nat Nanotechnol       Date:  2020-07-13       Impact factor: 40.523

Review 9.  Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases.

Authors:  Lev A Dykman
Journal:  Expert Rev Vaccines       Date:  2020-04-28       Impact factor: 5.217

Review 10.  Protein Supramolecular Structures: From Self-Assembly to Nanovaccine Design.

Authors:  Ximena Zottig; Mélanie Côté-Cyr; Dominic Arpin; Denis Archambault; Steve Bourgault
Journal:  Nanomaterials (Basel)       Date:  2020-05-25       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.